JPMORGAN CHASE & CO - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 160 filers reported holding CARDLYTICS INC in Q1 2022. The put-call ratio across all filers is 3.56 and the average weighting 0.7%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$378,345
+121.3%
22,930
-15.2%
0.00%
Q2 2023$170,969
-26.0%
27,052
-60.2%
0.00%
Q1 2023$231,000
+48025.0%
67,925
-18.4%
0.00%
Q4 2022$480
-99.9%
83,200
+3.7%
0.00%
Q3 2022$754,000
-77.8%
80,244
-47.4%
0.00%
Q2 2022$3,400,000
-97.1%
152,437
-92.8%
0.00%
-100.0%
Q1 2022$115,686,000
-15.0%
2,104,146
+2.1%
0.01%
-12.5%
Q4 2021$136,140,000
-11.7%
2,059,929
+12.1%
0.02%
-15.8%
Q3 2021$154,219,000
-31.5%
1,837,247
+3.5%
0.02%
-29.6%
Q2 2021$225,224,000
+10.0%
1,774,390
-4.9%
0.03%0.0%
Q1 2021$204,781,000
-1.2%
1,866,746
+28.6%
0.03%
-10.0%
Q4 2020$207,202,000
+319.5%
1,451,294
+105.7%
0.03%
+275.0%
Q3 2020$49,395,000
+16.1%
705,532
+16.1%
0.01%0.0%
Q2 2020$42,527,000
+239.9%
607,688
+69.8%
0.01%
+166.7%
Q1 2020$12,511,000
+522.7%
357,849
+1020.2%
0.00%
Q4 2019$2,009,000
-79.3%
31,946
-89.0%
0.00%
-100.0%
Q3 2019$9,704,000
+98.0%
289,498
+45.3%
0.00%
+100.0%
Q2 2019$4,901,000
+313.2%
199,301
+177.9%
0.00%
Q1 2019$1,186,000
+160.7%
71,705
+70.5%
0.00%
Q4 2018$455,000
+24.7%
42,063
+187.8%
0.00%
Q3 2018$365,000
-68.4%
14,613
-72.5%
0.00%
Q2 2018$1,156,000
+7125.0%
53,147
+4735.9%
0.00%
Q1 2018$16,0001,0990.00%
Other shareholders
CARDLYTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders